Jose E Almeida
CIK 1216761 · Chairman, CEO, President · last filed 2026-05-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
COV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
DEERFIELD, IL 60015
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BAC | Director | 33,606 | $50.68 | $1.70M | $0 | 5 | 2026-05-06 |
| BAX | Chairman, CEO, President | 568,565 | $26.42 | $15.02M | $499.8K | 23 | 2024-12-17 |
| Walgreens Boots Alliance, Inc. (WBA) Delisted | Director | 17,581 | $11.98 | $210.6K | $0 | 5 | 2021-11-03 |
| STT | Director | 5,191 | $171.62 | $890.9K | $0 | 2 | 2015-05-21 |
| ADI | Director | 230 | $393.30 | $90.5K | $0 | 2 | 2015-03-12 |
| Covidien plc (COV) Delisted | President and Chief Executive | 248,542 | — | — | -$26.25M | 57 | 2014-12-04 |
Recent Filings · Page 6 of 10
97 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-10-16 | STT | Grant (A) | +1,132 | $0 | EDGAR |
| 2013-09-30 | Covidien plc (COV) Delisted | Mixed | +21,876 | -$1.19M | EDGAR |
| 2013-08-16 | Covidien plc (COV) Delisted | Grant (A) | +552 | $34.1K | EDGAR |
| 2013-07-02 | Covidien plc (COV) Delisted | Tax (F) | −979 | -$56.2K | EDGAR |
| 2013-05-07 | Covidien plc (COV) Delisted | Grant (A) | +492 | $31.7K | EDGAR |
| 2013-02-14 | Covidien plc (COV) Delisted | Mixed | — | -$2.99M | EDGAR |
| 2013-01-03 | Covidien plc (COV) Delisted | Mixed | — | -$2.09M | EDGAR |
| 2012-12-28 | Covidien plc (COV) Delisted | Grant (A) | +551 | $31.6K | EDGAR |
| 2012-12-04 | Covidien plc (COV) Delisted | Mixed | +16,309 | -$515.9K | EDGAR |
| 2012-11-07 | Covidien plc (COV) Delisted | Grant (A) | +545 | $30.3K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.